Ready to Jump After Recent Trade: Angiodynamic Inc (ANGO)

With 0.46 million shares changed hands, the volume of the stock remained lighter than its average volume of 0.51 million shares. The 52-week range on ANGO shows that it touched its highest point at $12.62 and its lowest point at $5.26 during that stretch. It currently has a 1-year price target of $14.00. Beta for the stock currently stands at 0.66.

Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.

Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!

Get the FREE Report with all the details here.


Price Performance and Earnings:

Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of ANGO was up-trending over the past week, with a rise of 8.77%, but this was up by 6.19% over a month. Three-month performance dropped to -27.03% while six-month performance fell -20.36%. The stock lost -53.25% in the past year, while it has lost -25.64% so far this year. A look at the trailing 12-month EPS for ANGO yields -0.36 with Next year EPS estimates of -0.37. For the next quarter, that number is -0.14. This implies an EPS growth rate of -620.83% for this year and 15.03% for next year.

Float and Shares Shorts:

At present, 39.61 million ANGO shares are outstanding with a float of 38.57 million shares on hand for trading. On Mar 15, 2024, short shares totaled 2.46 million, which was 6.17% higher than short shares on Feb 15, 2024. In addition to AVGO as the firm’s Broadcom Inc., BNGO serves as its Bionano Genomics, Inc.

Institutional Ownership:

Through their ownership of 91.76% of ANGO’s outstanding shares, institutional investors have majority control over the company.

Analysts Ratings:

Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for ANGO since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential.

Dividends & Yield:

In terms of dividends, ANGO has a current ratio of $––, which is $–– over the trailing 12-months, while a dividend of $–– is likely to be paid on average over the next five years. Dividend yield is another indicator that appeals to many investors, and ANGO currently yields $0.00. In the past year, ANGO’s dividend yield has been $0.00, but when looking at the stock over the past five years, its yield has been $–. Accordingly, ANGO has a current buyback yield of $––. This was $–– for the TTM, and it was $–– for the past five years.